Las causas de reticencia a la vacunación contra la gripe en profesionales sanitarios de España: resultados de un estudio cuantitativo

Lucerón, Carmen Olmedo; Sánchez, Aurora Limia; Sánchez, Miguel de la Fuente; Moreno, Eva Galindo

doi:10.1016/j.vacun.2022.01.005

Cited by 6 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Seasonal influenza is an acute respiratory infection, preventable through vaccination, which causes between 3 and 5 million severe illness cases worldwide and between 290,000 and 650,000 deaths annually [1,2]. This results in a significant strain on health services, making annual vaccination a key public health intervention to reduce morbidity, mortality, and the socioeconomic burden of seasonal influenza [3][4][5]. It has been shown that annual vaccination reduces the risk of death and complications in people aged 65 or older [6][7][8].…”

Section: Introductionmentioning

confidence: 99%

The Impact of the COVID-19 Pandemic on Influenza Vaccination Attitudes and Actions in Spain’s Adult Population

Prada-García,

Toquero-Asensio,

Fernández-Espinilla

et al. 2023

Vaccines

View full text Add to dashboard Cite

Seasonal influenza is an acute respiratory infection caused by the influenza virus which constitutes a significant public health issue associated with high morbidity and mortality. The aim of this study was to investigate changes in attitudes, perceptions, and practices regarding influenza vaccination in the Spanish adult population during the COVID-19 pandemic, as well as their vaccination intentions, with special attention paid to those over 65 years old and in high-risk groups. To this end, a cross-sectional study was conducted through 2219 telephone interviews, and the results were compared with results obtained a year earlier. Regarding the reasons for deciding to get vaccinated in the 2022/23 season, a significant increase was observed in vaccine confidence (36.7% vs. 42.8%), social responsibility (32.5% vs. 43.8%), and in awareness of the importance of vaccination due to COVID-19 (21.7% vs. 25.4%). Advanced age (OR 2.8, 95% CI 2.0–3.9), belonging to high-risk groups (OR 2.7, 95% CI 2.0–3.7), and prior vaccination (OR 25.3, 95% CI 19.5–32.7) emerged as significant predictors for the intent to receive the influenza vaccine in the 2022/23 season. Continuously observing shifts in perceptions and behaviors related to influenza immunization is crucial to pinpoint factors that may influence the willingness to receive the vaccine and, in this way, design public health strategies that achieve a greater acceptance of it.

show abstract